Nutralife Financial Statements From 2010 to 2024
| NLBS Stock | USD 0.0001 0.00 0.00% |
Check Nutralife Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutralife Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Nutralife financial statements analysis is a perfect complement when working with Nutralife Biosciences Valuation or Volatility modules.
Nutralife |
Nutralife Biosciences Company Return On Equity Analysis
Nutralife Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nutralife Biosciences Return On Equity | -14.26 |
Most of Nutralife Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutralife Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nutralife Biosciences has a Return On Equity of -14.2602. This is 40.51% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Nutralife Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutralife Biosciences's current stock value. Our valuation model uses many indicators to compare Nutralife Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutralife Biosciences competition to find correlations between indicators driving Nutralife Biosciences's intrinsic value. More Info.Nutralife Biosciences is regarded third in return on equity category among its peers. It is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutralife Biosciences' earnings, one of the primary drivers of an investment's value.About Nutralife Biosciences Financial Statements
Nutralife Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Nutralife Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Nutralife Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Nutralife Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.